UTMB
Drs. Niesel and Herzog Medical Discovery News - bridging the world of medical discovery and you...
HomeAbout UsRadio ShowsPodcastListener QuestionsRadio StationsContactsReliable LinksStudents
 

Radio Shows | MDR Tuberculosis | mp3wmawav

Have you have heard about the attorney who exposed others to tuberculosis or TB on transatlantic flights? The TB he had was so serious the Centers for Disease Control detained and quarantined him upon his return to the US. The last time the CDC quarantined anyone was in 1963 for small pox.

This drastic step was taken because his TB was Multiply Drug Resistant. This means that it does not respond to common antibiotics. Plus TB is highly infectious; even a sneeze can release droplets that rapidly infect others.

So is it dangerous for TB patients to fly? You'd probably say yes until you consider that only a minority of people with TB are infectious and go on to develop the disease.

Also, airline personnel are unlikely to identify someone with TB since symptoms often don't show for years. And people may not know that they are infected.

The CDC has developed guidelines for TB patients. A person with normal TB should not travel until two weeks after drug treatment is initiated. However those with multiple drug resistant TB or an even more serious strain of TB called XDR should not travel until lab tests show they are non-infectious.

What are the risks to fellow passengers? Studies have found transmission of TB is more likely to happen on flights longer than eight hours. Furthermore, since only 25-50% of the air on a modern jet is re-circulated, studies show the risk is mostly limited to those surrounding the infected person.

It is clear that we need to identify and educate those infected with TB about the risks to themselves and others. Just as important, is the development of new antibiotics to control MDR and XDR TB.

Click here to email this page to a friend.


For more information…

The World Health Organization (WHO) is the directing and coordinating authority for health within the United Nations system. It is responsible for providing leadership on global health matters, shaping the health research agenda, setting norms and standards, articulating evidence-based policy options, providing technical support to countries and monitoring and assessing health trends. Anti-tuberculosis (TB) drug resistance is a major public health problem that threatens global tuberculosis control. The WHO provides a great deal of information of Multiple Drug Resistant TB.
For more information…

Q&A Related to CDC July 3, 2007 Press Conference with National Jewish Medical and Research Center concerning the patient with MDR TB who traveled internationally including a discussion of his reassessment from an XDR to MDR TB patient.
For more information…

The National Institute of Allergy and Infectious Diseases, a division of the National Institutes of Health that is responsible for conducting and supporting basic and applied research to better understand, treat, and ultimately prevent infectious, immunologic, and allergic diseases. NIAID provides an extensive website about TB including a history of TB, its causes, transmission, symptoms, diagnosis, treatment and prevention.
For more information…

The Nation's Health, the official newspaper of the American Public Health Association published an article entitled "Drug-resistant TB becoming more commonplace globally: High-profile U.S. case increases attention" by Kim Krisberg.
For more information…

A concise article about TB.

 
 

home | about us | radio shows | podcast | listener questions | radio stations | contact us | links | students | disclaimer

2006-2007 Drs. David Niesel and Norbert Herzog. All Rights Reserved.
The University of Texas Medical Branch. Please review our site policies.
Send mail to J. Junemann with questions or comments about this web site.